United Therapeutics Corporation shares owned by Tower View Investment Management & Research
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Tower View Investment Management & Research
from 13F filings
Historical chart of Tower View Investment Management & Research investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Tower View Investment Management & Research consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Tower View Investment Management & Research
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $31k | 75 | 419.21 |
| 2025-06-30 | $22k | 75 | 287.36 |
| 2025-03-31 | $23k | 75 | 308.28 |
| 2024-12-31 | $27k | 75 | 352.84 |
| 2024-09-30 | $36k | 100 | 358.35 |
| 2024-06-30 | $32k | 100 | 318.55 |
| 2024-03-31 | $23k | 100 | 229.72 |
| 2023-12-31 | $22k | 100 | 220.00 |
| 2023-09-30 | $23k | 100 | 230.00 |
| 2023-06-30 | $22k | 100 | 220.00 |
| 2023-03-31 | $22k | 100 | 220.00 |
| 2022-12-31 | $28k | 100 | 280.00 |
| 2022-09-30 | $21k | 100 | 210.00 |
| 2022-06-30 | $24k | 100 | 240.00 |
| 2022-03-31 | $18k | 100 | 180.00 |
| 2021-12-31 | $22k | 100 | 220.00 |
| 2021-09-30 | $15k | 79 | 189.87 |
| 2021-06-30 | $14k | 79 | 177.22 |
| 2021-03-31 | $13k | 79 | 164.56 |
| 2020-12-31 | $12k | 79 | 151.90 |
| 2020-09-30 | $8.0k | 79 | 101.27 |
| 2020-06-30 | $10k | 79 | 126.58 |
| 2020-03-31 | $7.0k | 79 | 88.61 |
| 2019-12-31 | $7.0k | 79 | 88.61 |
| 2019-09-30 | $6.0k | 79 | 75.95 |
| 2019-06-30 | $6.0k | 79 | 75.95 |
| 2019-03-31 | $9.0k | 79 | 113.92 |
| 2018-12-31 | $9.0k | 79 | 113.92 |
| 2018-09-30 | $10k | 79 | 126.58 |
More positions owned by Tower View Investment Management & Research
Home Depot (HD)
View all positions for Tower View Investment Management & Research
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation